Methylprednisolone Sodium Succinate for Injection USP 1 g. Exhibits greater anti-inflammatory potency than hydrocortisone and prednisolone; more effective than prednisolone in mediating long-term cytolysis and immediate inhibition of nucleoside uptake in human lymphoblastic cells. Indications: Severe Allergic Conditions (anaphylaxis, severe asthma, drug hypersensitivity), Autoimmune Disorders (rheumatoid arthritis, SLE, multiple sclerosis), Respiratory Disorders (COPD exacerbation, severe bronchial asthma), Ophthalmic Disorders (severe uveitis, optic neuritis), Neurological Conditions (acute exacerbations in MS, cerebral edema), and others (ulcerative colitis, nephrotic syndrome, severe skin disorders).
